Malaquin Syrup

About Malaquin 80 mg/5 ml Syrup

Malaquin Syrup is a chloroquine phosphate medicine in a liquid form, given as a syrup in a strength of 80 mg/5 ml. It is used in the treatment of malaria and some other conditions as decided by a doctor.

There are 24 brands of Chloroquine Phosphate listed in Bangladesh. The lowest listed price is Jasochlor 250 mg Tablet at ৳ 1.21 per unit.

What is Malaquin 80 mg/5 ml Syrup?

Malaquin Syrup is an anti-malarial medicine. Its active ingredient is chloroquine phosphate, supplied as a syrup at 80 mg/5 ml by United Chemicals & Pharmaceuticals Ltd. Chloroquine acts against the malaria parasite in the blood and is also used in some amoebic and inflammatory conditions. It is available only for use under medical guidance. A doctor decides whether it is suitable, the dose and how long it should be taken. Do not start, change or stop it without medical advice.

Uses of Malaquin

Malaquin Syrup is used for treating malaria and for preventing and suppressing it. It is also used in amoebic hepatitis and amoebic abscess, and in discoid and systemic lupus erythematosus and rheumatoid arthritis. Only a doctor can confirm which of these conditions applies to a patient and whether this medicine is appropriate.

How to use Malaquin

Give Malaquin Syrup by mouth as a syrup, using the measuring spoon or device supplied with the bottle. The doctor decides the dose and the course; do not change them yourself. Shake the bottle before use if the label says so, and store it at room temperature in a dry place away from light. Keep it out of reach of children.

Side effects of Malaquin

At standard doses chloroquine is usually well tolerated. Headache and stomach or bowel upset may occur. Longer use at higher doses can bring more serious effects, including skin rashes, occasional skin colour changes or hair loss, difficulty focusing, blurred vision, and corneal changes that clear after the drug is stopped. Rarely, low platelets, low white cells or aplastic anaemia have been reported. Retinal damage is the most serious hazard of prolonged use. Tell your doctor about any unusual symptom.

Safety and precautions

Tell your doctor before use if you have porphyria, especially with liver disease or cirrhosis, or if you drink alcohol regularly. Long-term or repeated use may need eye checks as the doctor advises. Avoid use in pregnancy if possible; the doctor will weigh benefit and risk if infection is threatening. Ask a doctor first if you are pregnant, planning pregnancy, breastfeeding, have liver or eye problems, or are taking other medicines.

Frequently asked questions

Which medicines may interact with Malaquin Syrup?

Phenylbutazone may raise the risk of dermatitis. Chloroquine can oppose neostigmine and pyridostigmine, and may reduce how much ampicillin the body absorbs. Cimetidine can slow chloroquine breakdown and raise its blood levels. Tell your doctor or pharmacist about all medicines you take, including ones bought without a prescription.

What is Malaquin Syrup used for and what kind of medicine is it?

It is an anti-malarial medicine containing chloroquine phosphate. It is used to treat malaria and to prevent and suppress it. It is also used in amoebic hepatitis and abscess, and in discoid and systemic lupus erythematosus and rheumatoid arthritis. A doctor decides if it is right for you.

What do the dosage form and strength mean?

The dosage form is a syrup, a liquid taken by mouth, which can be measured with a spoon or dosing device. The strength 80 mg/5 ml means each 5 ml of the syrup contains 80 mg of chloroquine phosphate. The doctor decides how much and how often to give.

Who should ask a doctor before using it?

Ask a doctor first if you are pregnant, planning pregnancy or breastfeeding, have porphyria or liver disease, have eye problems, drink alcohol regularly, or take other medicines. The doctor will check whether Malaquin Syrup is suitable and arrange any monitoring, such as eye checks, that may be needed.

Also available as

250 mg (Tablet)

Indications

Chloroquine Phosphate is indicated in the following cases:
  • Treatment of malaria
  • Prophylaxis and suppression of malaria
  • Treatment of amoebic hepatitis and abscess
  • Treatment of discoid and systemic and systemic lupus erythematosus
  • Treatment of rheumatoid arthritis

Pharmacology

Chloroquine is used for malarial prophylaxis (as a suppressive) and in managing acute attacks of malaria. It is highly active against erythrocytic forms of P. vivax, P. malariae and P. falciparum. It influences Hb digestion by increasing intravesicular pH in malaria parasite cells and interferes with the nucleoprotein synthesis of the patient. It is also effective in extra intestinal amoebiasis. In RA chloroquine and more effectively hydroxychloroquine have a disease-modifying effect.

Dosage & Administration

Treatment of Malaria-

Partially immune adults:

A single dose of 4 tablets. In severe attacks, the dosage schedule for non-immune adults should be adopted.

Partially immune children:

  • Under 1 year: 1-2 single dose (in 5 ml spoonful)
  • 1-3 years: 3-4 single dose (in 5 ml spoonful)
  • 3-6 years: 4-6 single dose (in 5 ml spoonful)
  • 6-9 years: 6-9 single dose (in 5 ml spoonful)
In severe attacks, the dosage schedule for non-immune children should be adopted.

Non-immune adults:

  • P. falciparum infections: 4 tablets initially, 2 tablets after 6 to 8 hours and then 2 tablets per day for 2 days
  • P. vivax group infections: A single dose of four tablets followed by a course of treatment with primaquine phosphate (15 mg base daily for fourteen days)

Non-immune Children:

Under 1 year:
  • 1-2 initial dose (in 5 ml spoonful)
  • 1 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
1-3 years:
  • 3-4 initial dose (in 5 ml spoonful)
  • 1-2 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
3-6 years:
  • 4-6 initial dose (in 5 ml spoonful)
  • 2-3 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
6-9 years :
  • 6-9 initial dose (in 5 ml spoonful)
  • 3-5 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)

Prophylaxis and suppression of Malaria-

Adults: 2 tablets taken once a week, on the same day each week, during exposure to risk and continued for 6 weeks after leaving the malarious area.

Children (Syrup): The following doses should be taken once a week, on the same day each week, during exposure to risk and continued for 6 weeks after leaving the malarious area.
  • Under 1 year: 1 single dose (in 5 ml spoonful)
  • 1-3 years: 2 single dose (in 5 ml spoonful)
  • 3-6 years: 2-3 single dose (in 5 ml spoonful)
  • 6-9 years: 3-5 single dose (in 5 ml spoonful)
Children (Tablets): For practical purpose, children over 12 years may be treated as adults and for those below this age, the following proportions may be applied.
  • Under 1 year: ⅛ adult dose (¼ tablet)
  • 1-4 years: ¼ adult dose (½ tablet)
  • 4-8 years: ½ adult dose (1 tablet)
  • 8-12 years: ¾ adult dose (1.5 tablet)

Interaction

Concomitant therapy with phenylbutazone predisposes to dermatitis, antagonises effect of neostigmine and pyridostigmine, reduces bioavailability of ampicillin. Cimetidine inhibits metabolism of chloroquine raising plasma levels.

Contraindications

There is no absolute contraindication to the use of chloroquine.

Side Effects

Choroquine is well tolerated at the standard dosage regimens, side effects such as headache and gastrointestinal disturbances which may occur are not of a serious nature. Where prolonged high dose is required side effects can be of greater severity and patients may develop skin eruptions, occasional depigmentation or loss of hair, difficulty in accommodation, blurring of vision. Corneal opacities disappear completely when the drug is stopped. Rarely thrombocytopenia, agranulocytosis and aplastic anemia have been reported.

The most serious toxic hazard of prolonged therapy with doses is the occasional development of irreversible retinal damage. For this reason considerable caution is needed in the use of choroquine for long-term high dosage therapy and such use should only be considered when no other drug is available. Defects in visual accommodation may occur on first taking choloquine and patients should be warned regarding driving or operating machinery.

Pregnancy & Lactation

As with all other drugs, the use of choroquine during pregnancy should be avoided if possible, unless in the case of threatening infections, in the judgment of the physician, when the potential benefit outweighs the risk.

Precautions & Warnings

Caution is necessary when giving choroquine to patients with porphyria who also have hepatic dysfunction or cirrhosis as the drug may precipitate severe constitutional symptoms and an increase in the amount of porphyrins excreted in the urine. This reaction is especially apparent in alcoholics. Patients receiving choloquine continuously at higher dose levels for a period longer than 12 months or at weekly intervals for a period of more than 3 years as prophylactic against malaria (or the consumption exceeds 1.6 g/Kg) should undergo ophthalmic examination at three months interval.

Storage Conditions

Store at room temperature in a dry place, away from light.

Alternative brands of Chloroquine Phosphate

Other brands with the same generic name, cheapest first.

See all 24 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.